ArticleMolecular oncology2015

Inhibition of ligand-independent constitutive activation of the Met oncogenic receptor by the engineered chemically-modified antibody DN30.

Elisa Vigna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.